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In survival analysis, time-varying covariates are covariates whose value can
change during follow-up.Outcomes inmedical research are frequently subject to
competing risks (events precluding the occurrence of the primary outcome). We
review the types of time-varying covariates and highlight the effect of their inclu-
sion in the subdistribution hazard model. External time-dependent covariates
are external to the subject, can effect the failure process, but are not otherwise
involved in the failure mechanism. Internal time-varying covariates are mea-
sured on the subject, can effect the failure process directly, and may also be
impacted by the failure mechanism. In the absence of competing risks, a con-
sequence of including internal time-dependent covariates in the Cox model is
that one cannot estimate the survival function or the effect of covariates on the
survival function. In the presence of competing risks, the inclusion of internal
time-varying covariates in a subdistribution hazard model results in the loss
of the ability to estimate the cumulative incidence function (CIF) or the effect
of covariates on the CIF. Furthermore, the definition of the risk set for the
subdistribution hazard function canmake defining internal time-varying covari-
ates difficult or impossible. We conducted a review of the use of time-varying
covariates in subdistribution hazard models in articles published in the medi-
cal literature in 2015 and in the first 5 months of 2019. Seven percent of articles
published included a time-varying covariate. Several inappropriately described
a time-varying covariate as having an association with the risk of the outcome.
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1 INTRODUCTION
Survival analysis is concerned with outcomes that occur over time. Examples include time to all-cause death and time to
cause-specific death (eg, time to death due to cardiovascular causes). A key feature of survival analysis is that of censoring:
the study may be terminated or subjects may be lost to follow-up before the event of interest has been observed to occur
for all subjects. Another important concept is that of competing risks. A competing risk is an outcome whose occurrence
precludes the occurrence of the event of interest. For instance, subjects who die of noncardiovascular causes are no longer
at risk of death due to cardiovascular causes.
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Time-varying (or time-dependent) covariates occur frequently in biomedical and epidemiological research. These are
covariates whose values change over the duration of follow-up. Examples include biomarkers that change over follow-up
(eg, prostate specific antigen [PSA]) or cumulative exposure to medications.1 A time-invariant (or time-fixed) covariate is
a covariate whose value remains unchanged or fixed throughout the entire duration of follow-up.
The use of hazard-based regression models is ubiquitous in medical and epidemiological research. The most common
of these is the Cox proportional hazards regressionmodel that allows one to estimate the effect of covariates on the hazard
of the occurrence of the outcome.2 In the absence of competing risks and with only time-invariant covariates, one is able
to estimate the probability of the occurrence of the event within any duration of time from the fitted Cox proportional
hazards model. However, this may no longer be possible when the model incorporates time-varying covariates.
In the presence of competing risks with either time-varying or time-invariant covariates, the Cox proportional hazards
regression model for the cause-specific hazard function does not permit estimation of the effect of covariates on the
cumulative incidence of the outcome or estimation of the probability of the event occurring within a given duration of
follow-up time. The Fine-Gray subdistribution hazard regression model permits estimation of the effect of time-invariant
covariates on the cumulative incidence of the event in the presence of competing risks.3 Similarly to the Cox proportional
hazards model without competing risks, the Fine-Gray subdistribution hazard model must be interpreted carefully when
time-varying covariates are included in the model specification. In many scenarios, one loses the ability to estimate the
effect of the covariate on the cumulative incidence function (CIF) and to estimate the probability of the event occurring
in a given time period.
The objectives of the current paper are twofold. First, to describe the different types of time-dependent covariates and
clarify when hazard-based regression models can be interpreted in terms of the cumulative incidence, both with and
without competing risks. Special emphasis is given to the Fine-Gray model. Second, to review the medical literature
to determine the frequency with which time-varying covariates are incorporated into Fine-Gray subdistribution hazard
regression models and how authors interpret the resultant models.
2 TIME-VARYING COVARIATES AND CUMULATIVE INCIDENCE
In this section, we introduce notation and definitions. We then summarize existing knowledge on the effect of including
time-varying covariates in the conventional Cox model and the Fine-Gray subdistribution hazard model. We discuss the
effect of their inclusion on the interpretation of the resultant regression coefficients.
2.1 Definitions and notation
The survival function, S(t), is the probability that an individual survives to time t: S(t) = Pr(T > t), where T denotes the
time to the occurrence of the event of interest. The complement of the survival function is the cumulative distribution
function, which describes the cumulative incidence of the event of interest up to time t: F(t) = 1 − S(t).
The hazard function, λ(t), is the instantaneous rate of the occurrence of the event of interest in subjectswho are currently
at risk of the event: 𝜆(t) = limΔt→0 Pr(t<T≤t+Δt|T>t)Δt . The survival function and the hazard function are related through the
following relationship: S(t) = exp(−Λ(t)), where Λ(t) = ∫ t0 𝜆(s)ds denotes the cumulative hazard function (alternatively,
Λ(t) = − log(S(t))).4
The Cox proportional hazards regression model allows one to estimate the relative effect of covariates on the hazard
function.2 The Cox model can be formulated in multiplicative form as 𝜆(t|X) = 𝜆0(t)e𝛃X, where X denotes a vector of
covariates, 𝛃 denotes a vector of regression coefficients, and 𝜆0(t) denotes the baseline hazard function for a subject whose
covariates are all equal to zero.
A time-varying covariate, X(t), is a covariate whose value can change over the duration of follow-up (eg, time-varying
biomarkers [eg, PSA], current use ofmedication, and cumulative dose ofmedication). Kalbfleisch andPrentice distinguish
between two different types of time-varying covariates: external and internal covariates.5 They define these as “an external
covariate is one that is not directly involved with the failure mechanism, and an internal covariate is a time measurement
that is taken on the individual” (page 123). External covariates can effect the failure process directly, but are not otherwise
involved in the failure mechanism, while internal covariates can effect the failure process, but can also be impacted by
the failure mechanism (eg, there may be feedback between the time-varying covariate and failure process). There are
two subfamilies of external covariates: external defined covariates and external ancillary covariates. External defined
covariates are those covariates whose values are defined or determined for all subjects prior to the commencement of
the study. An example would be a controlled experiment studying the effect of cumulative radiation dose, where the
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(cumulative) radiation dose, as a function of time, is known and defined prior to the beginning of the study. Thus, for
external defined covariates, the function X(t) would be defined for all subjects and for all times t, regardless of whether the
subject was currently under observation. An external ancillary covariate is a covariate that is the result of a stochastic or
randomprocess that is external to the subjects in the study. Kalbfleisch and Prentice suggest that airborne pollutionwould
be an external ancillary covariate in a study on asthma attacks, as the probability distribution of airborne pollution is likely
independent of subject characteristics that would be included in the hazard regression model. In contrast to an external
covariate, Kalbfleisch and Prentice define an internal covariate to be “the output of a stochastic process that is generated
by the individual under study and so is observed only so long as the individual survives and is uncensored. In consequence,
its observed value carries information about the survival time of the corresponding individual” (page 124). It can be
argued that the large majority of time-varying covariates encountered in biomedical research are internal time-varying
covariates. Examples include organ transplantation, time-varying biomarkers (eg, PSA), presence of infection, current use
of medication in observational studies, and cumulative dose of medication in observational studies where the dose is not
actively manipulated by the investigator according to a previously defined mechanism.
It iswell known that theCox proportional hazardsmodel can incorporate time-varying covariates, with the usual formu-
lation being: 𝜆(t|X(s), s≤ t)= 𝜆0(t)e𝛃X(t). As with the conventional Coxmodel with time-invariant covariates, the inclusion
of time-varying covariates allows one to estimate the effect of covariates on the instantaneous hazard of the event. The
model can also incorporate time-varying covariate effects (ie, the effect of a given covariate on the instantaneous hazard
of the event changes over time). However, we do not consider time-varying covariate effects in this paper.
2.2 Relationship of hazard and survival functions in the absence of competing risks
and with time-invariant covariates
Assume that we are in a setting without competing risks and such that all covariates are fixed at baseline. From the
conventional Cox model for the hazard function, we can derive the following relationship to the survival function:
S(t|X) = S0(t)e𝛃X (see Appendix). Applying a log-log transformation, we have that log(log(S(t|X)) = log(S0(t))+𝛽X. Thus,
the regression coefficients from the Cox regression model can be interpreted as having an effect on the survival function.
In particular, if a covariate increases the hazard of the occurrence of the event (β > 0), it will also increase the incidence
of the event.6
2.3 Survival and hazards in the absence of competing risks and with time-varying
covariates
In the previous section, we demonstrated that the survival function could be estimated as a function of the baseline sur-
vival function and the linear predictor from theCox proportional hazardsmodel in the absence of competing risk andwith
time-invariant covariates. Thus, the regression coefficients can be interpreted as having an effect on the survival function.
However, with time-varying covariates, this interpretation only holds when the hazard regression model includes exter-
nal time-varying covariates and not with internal time-varying covariates. To see how this arises more clearly, as above,
without covariates, we have that the survival function is related to the cumulative hazard function: S(t) = exp(−Λ(t)). In
the absence of competing risks, the CIF is equal to 1 − exp(−Λ(t)). Given the Cox regression model with time-varying
covariates, we have that
𝜆(t|X(s), s ≤ t) = 𝜆0(t)e𝛃X(t), integrating both sides yields
t
∫
0
𝜆(s|X(u),u ≤ s)ds =
t
∫
0
𝜆0(s)e𝛃X(s)ds.
Note that, in the above integral, the term exp(𝛃X(s)) cannot be brought outside of the integral because it is a function of
the variable of integration. This complicates the interpretation of the regression parameters in the proportional hazards
model.
There are two different scenarios that we must consider. The first scenario is when the time-varying covariate is an
external defined covariate. In this setting, the usual relationship between the hazard and the CIF holds, such that S(t) =
exp(− ∫ t0 𝜆(s)𝑑𝑠) = exp(− ∫ t0 𝜆0(s)e𝛽X(s)ds) (note that, in the presence of time-varying covariates, the survival function of
interest is defined formally as S(t|X(s), s ≤ t) = Pr(T > t|X(s), s ≤ t); however, we use the simpler notation when it is clear
from the context what is intended). For external time-varying covariates, X(t) is known even when a subject is not under
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observation and the above integral can be evaluated and has a clear probabilistic interpretation. However, one cannot
bring the term exp(𝛃X(s)) outside of the integral and have it multiply the resultant cumulative baseline hazard function.
Consequently, in general, we can no longer make simple claims that a covariate that has an effect on the hazard of the
outcomehas an effect of the same direction on the cumulative incidence of the outcome, as it depends on the entire history
of the time-varying covariate. Greater care is needed in such statements. In comparing two individuals with covariates
X1(t) and X2(t), with X1(t) ≤ X2(t) for at all t, then 𝛽 > 0 implies that the cumulative incidence for individual 2 with
covariate X2(t) is greater than for individual 1 with covariate X1(t) at all time points, and vice versa if 𝛽 < 0. When X1(t)
and X2(t) are not strictly ordered, it is challenging to compare the CIFs for the two subjects, which depends not only on 𝛽
and the history of the time-varying covariates but also the baseline hazard function.
The second scenario is when the time-varying covariate is an internal covariate. As such there is almost never a defined
stochastic model or known functional form for the covariate. Furthermore, even if this were known, it is questionable
whether it would be valid when the individual is no longer under observation. In particular, once the individual has
experienced the event, the value of the covariate is no longer known. Thus, in this setting, the required integral cannot be
evaluated and the usual relationship between the hazard and survival function no longer exists. Thus, one cannot estimate
the effects of internal time-varying covariates on the survival function via a proportional hazards model. Accordingly, one
cannot obtain an estimate of the survival function or of the CIF.
2.4 Cumulative incidence and hazards in the presence of competing risks and with
time-invariant covariates
As shown in Section 2.2, in the absence of competing risks, there is a one-to-one correspondence between the effect of
a covariate on the hazard function and its effect on the survival function. In particular, a covariate that increases the
hazard of an event will also increase the incidence of the event. In the presence of competing risks, this is no longer
necessarily true.3 Specifically, when one naively treats competing events as censoring events and implicitly fits a model to
the cause-specific hazard function for the event of interest. To address this issue, Fine and Gray introduced a proportional
hazards model for the subdistribution hazard function for the kth type of event
𝜆sdk (t) = limΔt→0
Prob (t ≤ T ≤ t + Δt,D = k|T ≥ t ∪ (T ≤ t ∩ D ≠ k))
Δt ,
where D is a variable denoting the type of event that occurred. There is a different subdistribution hazard function for
each of the K different types of events. The subdistribution hazard function for a given type of event is defined as the
instantaneous rate of occurrence of the given type of event in subjects who have not yet experienced an event of that type.3
Note that the risk set consists of those subjects who are either currently event-free or who have previously experienced a
competing event. In subsequent discussions, it will be important to recall that subjects who experience a competing event
remain in the risk set.
The Fine-Gray subdistribution hazard model estimates the effect of covariates on the subdistribution hazard function
via themodel 𝜆sdk (t|X) = 𝜆sdk0(t)exp(X𝛽), where 𝜆sdk0(t) denotes the baseline subdistribution hazard function for the kth event
type. In the absence of time-varying covariates, there is a one-to-one relationship between the subdistribution hazard
function and the CIF, which describes the incidence of the occurrence of an event while taking competing risks into
account. Thus, the subdistribution hazard model allows one to estimate the effect of covariates on the CIF for the event
of interest. In particular, one may recover a relationship similar in form to that described above
1 − CIFk(t|X) = (1 − CIFk0(t))exp(X𝛃), (1)
where CIFk(t |X) = Pr (T ≤ t, event type= k |X), and where CIFk0 denotes the baseline CIF: CIFk0(t) = Pr (T ≤ t,
event type = k |X = 0). By using the log-log transformation, this can be written as a linear model: log (log(1−
CIFk(t |X)))= log(log(1− CIFk0(t))) +X𝛽. Thus, if a covariate is associated with an increase in the subdistribution hazard
function, it will also be associated with an increase in the cumulative incidence of the event. Thus, in the absence of
time-varying covariates, the use of the Fine-Gray subdistribution hazard model allows for inferences about the effect of a
covariate on the incidence of the outcome.
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2.5 Incidence and hazards in the presence of competing risks with time-varying
covariates
In the original paper developing the subdistribution hazard regression model, the model was extended to include
time-varying covariates. However, inclusion of time-varying covariates requires caution in all instances and can be
problematic in some. Furthermore, the resultant regression coefficients must be interpreted carefully.
We define the CIF in the presence of time-varying covariates as CIFk(t|X(s), s≤ t)= Pr(T≤ t |X(s), s≤ t). Then, the sub-
distribution hazard regression model with time-varying covariates can be written as 𝜆sd1 (t|X(s), s ≤ t) = 𝜆sd10(t)exp(X(t)𝛽).
Consequently, we have that CIF1(t|X(s), s ≤ t) = 1 − exp [− ∫ t0 𝜆sd10(s|X(u),u ≤ s)du] = 1 − exp[− ∫ t0 𝜆sd10(s)eX(s)𝛃ds].3
Note that in the above integral, the term exp(X(s)𝛃) cannot be brought outside of the integral because it is a func-
tion of the variable of integration. This complicates the interpretation of the regression parameters in the proportional
subdistribution hazard model.
There are two different scenarios that we must consider. The first scenario is when the time-varying covariate is an
external defined covariate. In this setting, the usual relationship between the subdistribution hazard and the CIF holds,
such that CIFk(t|X(s), s ≤ t) = 1 − exp(−Λ(t|X(s), s ≤ t)) = 1 − exp(− ∫ t0 𝜆sdk0(s)e𝛽X(s)ds). For external time-varying covari-
ates, X(t) is known even when a subject is not under observation and the above integral can be evaluated and has a clear
probabilistic meaning. However, one cannot bring the term exp(𝛃X(s)) outside of the integral. Consequently, in general,
we can no longer make simple claims that a covariate that has an effect on the subdistribution hazard of the outcome
has an effect of the same direction on the cumulative incidence of the outcome, as it depends on the entire history of the
time-varying covariate. We emphasize that the evaluation of the integral ∫ t0 𝜆sd10(s)eX(s)𝛃ds is always possible for external
time-varying covariate. In practice, an internal time-varying covariate may not be fully observed, complicating the eval-
uation of the integral. This is similar to the conventional Cox model without competing risks, where the evaluation of
the integral requires that the time-dependent covariate is completely observed over time. It follows heuristically that the
connection between the subdistribution hazard and the CIF is only valid with external time-dependent covariates and
the interpretation of the Fine-Gray model with internal time-dependent covariates is only valid for the subdistribution
hazard and not the CIF. Such interpretation is addressed more carefully below.
A different problem presents itself in the setting of internal time-varying covariates. Several sets of authors have noted
that an unconventionality in the definition of the risk set for the subdistribution hazard function makes the inclusion of
internal time-varying covariates problematic.7-9 As noted above, the risk set for the subdistribution hazard function con-
tains those subjects who have failed due to competing events. Incorporating time-varying covariates into the Fine-Gray
subdistribution hazardmodel requires that we know the value of these covariates for the entire time that a subject remains
in the risk set. When a subject has failed from a competing event, the model requires that the value of the time-varying
covariate can be fully specified over time. For competing events that include death (or cause-specific death), one will, in
general, not know the value of the time-varying covariate once the subject has died. For instance, consider the setting in
which the event of interest is death due to cardiovascular causes and death due to noncardiovascular causes is the com-
peting event. Elevated blood pressure (hypertension) is a known risk factor for cardiovascular disease.10 To include blood
pressure as a time-varying covariate would require knowing a subject's blood pressure after he or she had experienced a
competing event (death due to noncardiovascular causes), as he or she remains in the risk set. However, it is not clear how
blood pressure should be defined after noncardiovascular death. For this reason, defining internal time-dependent covari-
ates after the occurrence of the competing event (noncardiovascular death) may be difficult or impossible. This issue has
been considered in the literature, for example, in the work of Beyersmann and Schumacher,8 where ad hoc approaches to
extrapolating the internal time-dependent covariate, such as last value carried forward, have been proposed. The use of
such techniques leads to an implicit definition of the subdistribution hazard that may be difficult to interpret and should
be used with great caution.
3 LITERATURE REVIEW OF THE USE OF TIME-VARYING COVARIATES
WITH THE FINE-GRAY SUBDISTRIBUTION HAZARD MODEL
In the previous section, we discussed the inclusion of time-varying covariates in the Fine-Gray competing risk regression
model. In this section, we report on a literature review that examined the frequency with which time-varying covariates
were included in the subdistribution hazard model in two different periods in the medical literature. We also report on
how the resultant model was interpreted.
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We used a search strategy based on that used in a recently-published review examining how authors in the biomed-
ical literature interpreted the regression coefficients from a Fine-Gray regression model.11 The search was conducted
in two distinct time periods. We searched the PubMed database (https://www.ncbi.nlm.nih.gov/pubmed) using two
search strategies to identify papers that used the Fine-Gray subdistribution hazard model: (i) (“subdistribution haz-
ard”[All Fields]OR “Fine-Gray”[All Fields]) AND (“2015/01/01”[PDAT]: “2015/12/31”[PDAT]) and (ii) (“subdistribution
hazard”[All Fields] OR “Fine-Gray”[All Fields]) AND (“2019/01/01”[PDAT]: “2019/05/31”[PDAT]). The first strategy
identified papers published in 2015, while the second identified papers published in the first 5 months of 2019. The first
search strategy was identical to that which we used in an earlier review.11 The second search strategy was conducted on
June 6, 2019.
The first search process identified 64 papers published in 2015. Of these, eight methodologically-oriented publications
were excluded. One paper was excluded because it did not use the Fine-Gray subdistribution hazardmodel. We examined
the remaining 55 papers to see whether the authors incorporated time-varying covariates into the Fine-Gray subdistri-
bution hazard model. The second search process identified 108 papers published in the first 5 months of 2019. Of these,
five methodologically-oriented publications were excluded, and one paper was excluded because an English-language
version was not available. We examined the remaining 102 papers to see whether the authors incorporated time-varying
covariates into the Fine-Gray subdistribution hazard model.
Of the 55 papers published in 2015, six (11%) included time-varying covariates in Fine-Gray subdistribution hazard
model.12-17 Of the 102 papers published in the first 5 months of 2019, five (5%) included time-varying covariates in the
Fine-Gray subdistribution hazard model.18-22 These 11 papers are summarized in Table 1.
Across the 11 studies, all but two of the time-varying covariates were internal covariates. Age and calendar year of
follow-up can be thought of as external time-varying covariates, as they can be fully specified at all time points after
baseline, regardless of whether the subject had experienced a competing event. Several of the covariates (eg, cumulative
dose of metformin, undergoing opioid substitution therapy, number of episodes of opioid substitution therapy, use of
neck radiotherapy, cumulative thyroid stimulating hormone level, and radioiodine dose) could be external time-varying
covariates in a controlled experimental study in which these variables were dictated by a protocol that was pre-specified
and under the control of the investigator. However, the studies in which these time-varying covariates were used were
retrospective observational studies in which the study investigators passively recorded the treatments and exposures that
had been applied. Accordingly, these variables are all internal time-varying covariates. Nine of the 11 studies had at least
one binary (or categorical) internal time-varying covariate. It was difficult to determine how the internal time-dependent
covariates were coded for subjects who experienced a competing event.
Of the 11 studies that incorporated time-varying covariates, six (55%) provided, in at least one instance, an interpretation
that suggested that the time-varying covariate was associated with the risk of the event.12,13,17-19,21 As risk has a distinct
probabilistic interpretation, it appears that these authors were suggesting that the time-varying covariate was associated
with the CIF. In the remaining papers, one set of authors explicitly noted that “cumulative incidence functions cannot
be interpreted for time-varying risk factors”15 (page 1172). In the papers that did not infer an association between the
time-varying covariate and the risk of the event, the authors restricted themselves to the reporting of subdistribution
hazard ratios or describing the effect of the time-varying covariate in terms of its association with the rate or hazard of
the outcome. These results are important, as they provide information as to how authors think their results should be
interpreted, regardless of whether the interpretation is valid.
4 DISCUSSION
The Fine-Gray subdistribution hazard model is increasingly being used for the analysis of time-to-event outcomes in
the presence of competing events. However, many applied analysts and clinical researchers appear to be unaware that
incorporating time-dependent covariates in the Fine-Gray model requires considerable care and that their inclusion may
have undesirable effects on the interpretability of the resultant model.
The focus of the current paper is on the use of time-varying covariates with the Fine-Gray subdistribution hazard
model. However, similar issues arise with the conventional Cox proportional hazards model in the absence of competing
risks. When including time-varying covariates in a conventional Cox regression model, one can still estimate the effect of
covariates on the hazard function. However, one may lose the ability to estimate the effect of covariates on the survival
function and to make inferences about the direction of the effect of the covariate on the incidence of the outcome
(see Section 2.3).
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TABLE 1 Papers reporting time-varying covariates in a Fine-Gray subdistribution hazard model
Author Primary outcome Competing risk Binary time- Continuous time-
varying covariate varying covariate
Han et al12 Cervical cancer- Death from other Cumulative dose
specific mortality causes of metformin
after cervical
cancer diagnosis
Ong et al13 Death Discharge from The occurrence
the ICU of a specific
infection
Dautzenberg et al15 ICU mortality ICU discharge Colonization by
a specific organism
Vajdic et al16 Cause-specific Deaths from Specific Age, calendar
mortality other causes infections and year of follow-
undergoing up, and number
opioid of episodes of
substitution opioid
therapy substitution
therapy
Ong et al14 Mortality Liberation from Viral reactivation
mechanical status
ventilator
support
Klein Hesselink et al17 Atrial fibrillation All-cause Use of neck Cumulative
mortality radiotherapy thyroid
stimulating
hormone level
and radioiodine dose
Aksnessaether et al18 Second cancer Death Treatment
Li et al19 Acute coronary Death Antiviral
syndrome/end- treatment
stage renal
disease/ischaemic
stroke/retinopathy
Deka et al20 Development of Death Androgen
depression deprivation
therapy
Mori et al21 TCZ TCZ Clinical Disease
discontinuation discontinuation Activity Index
due to secondary due to remission (as binary or
loss of efficacy or other reasons categorical
variable)
Yaffe et al22 Dementia Death Number of
follow-up visits
per year
Several sets of authors have highlighted how the unconventionality of the risk set for the Fine-Gray subdistribution
hazard model makes the inclusion of internal or subject-level time-varying covariates problematic.7-9 The risk set con-
tains those subjects who have experienced a competing event. However, their inclusion in the risk set requires that the
value of the time-dependent covariate be known for these subjects after they have experienced a competing event. If the
competing event includes death or cause-specific death, then it will typically not be possible to know the value of the
time-varying covariate after the subject has died and ad hoc approaches for extrapolation are needed, complicating the
interpretation of the model. Our review of the use of the Fine-Gray subdistribution hazard model in the medical litera-
ture highlights that, despite this fact being known to those who are experienced with competing risks regression models,
it appears to be unfamiliar to many applied analysts and clinical researchers. We observed that the inclusion of internal
time-varying covariates in a Fine-Gray subdistribution hazard model was not uncommon in the medical literature, with
the presentation being unclear and potentially inappropriate.
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Beyersmann and Schumacher used the relationship between discrete covariates and multistate models to develop an
approach to incorporate time-dependent covariates in a subdistribution hazards framework.8 However, in a recent study,
Poguntke et al used simulations to examine the impact of including time-varying covariates in subdistribution hazard
models.23 When they simulated data under a setting in which the time-varying covariate had no association with the
incidence of the primary outcome, they detected a non-null subdistribution hazard ratio. Consequently, they strongly
recommended “avoiding the use of the subdistribution approach for assessing the effect of a time-dependent covariate”23
(page 9). However, this latter paper did not distinguish between internal and external time-dependent covariates and
their conclusions should be considered to apply to the setting with internal time-dependent covariates. Importantly, for
external covariates, valid inferences about the CIF may be obtained from the subdistribution hazard model, similar to
data without competing risks where the survival function may be obtained from the proportional hazards model.
When the focus is on prediction or estimation of the CIF in the presence of internal time-varying covariates,
Cortese et al describe how the Fine-Gray model can be combined with a landmark approach to estimate cumulative
incidence.24 This approach is based on a similar approach described by vanHouwelingen for usewith the all-cause hazard
model and the cause-specific hazard model.25 This approach entails defining a set of k landmark times: {si : i = 1, … , k}.
One then conducts a sequence of conventional competing risks survival analyses with time-invariant covariates at each
of the k landmark times. The ith landmark analysis is restricted to those subjects who are at risk of the event at the ith
landmark time (ie, those subjects who have not experienced the primary outcome of interest or a competing event prior
to time si). The covariates for the ith landmark analysis are fixed at their values at time si. Thus, in the ith landmark anal-
ysis, one is estimating Pr(T ≤ t,D = 1 ∣ T ≥ s,X(s)). The vector X(s) denotes the values of the covariates at time s and is
treated as a time-invariant covariate in this analysis. Thus, a conventional Fine-Gray subdistribution hazard model can
be used to model the incidence of the outcome conditional on survival to time s and on the values of the covariates at
time s. When prediction of incidence or survival probabilities is of interest, this approach may provide easier and more
transparent interpretations with internal time-dependent covariates for survival data both with and without competing
risks. It should be noted that the use of landmarking comes at the cost of increasing variability (or decreasing precision)
of the estimates with increasing landmark time (or as the size of the risk set decreases).
Even when a well-defined time-dependent covariate is included in a Fine-Gray subdistribution hazard model, unantic-
ipated consequences may arise of which the applied analyst or clinical researcher may be unaware. An appealing feature
of the Fine-Gray subdistribution hazard model, and indeed the motivation for its development, is the ability to make
inferences about the effect of covariates on the CIF in the presence of competing risks (which cannot be done with the
conventional Cox regression model for the cause-specific hazard function). However, this capacity is lost when incor-
porating internal time-varying covariates, similarly to the proportional hazards model without competing risks. Thus,
while the inclusion of such time-varying covariates in the Fine-Gray model permits one to interpret the covariates as hav-
ing an effect on the subdistribution hazard of the primary event, that is, on the rate of the event in those subjects who
have not yet experienced that event, it no longer permits inferences about the association of a covariate with the CIF or
the incidence of the event. As we have noted elsewhere, this interpretation can be difficult for many to conceptualize11
and is less appealing than an interpretation about the effect of the covariate on the CIF. Furthermore, the study by
Poguntke et al suggests that the estimated subdistribution hazard ratio may be misleading when the time-dependent
covariate is an internal time-dependent covariate.
van Walraven and McAlister examined 100 studies published in 2013 in prominent medical journals.26 Of these 100
studies, 46% contained Kaplan-Meier analyses that were susceptible to competing risks bias. Similarly, Schumacher et al
conducted an examination of the presence of competing risk bias in 2015 in a prominent medical journal.27 In 51 articles
in which competing risks were present, 25 (49%) were susceptible to competing risk bias (eg, a Kaplan-Meier survival
function was estimated rather than a CIF). We recently published two reviews addressing issues related to the handling
of competing risks in the medical literature. The first review examined how competing risks were addressed in reports
of randomized controlled trials (RCTs) published in four leading general medical journals.28 We estimated that 77.5% of
RCTs with a time-to-event outcome were potentially susceptible to competing risks. Of those studies that were poten-
tially susceptible to competing risks, 77.4% reported the results of a Kaplan-Meier survival analysis, while only 16.1%
reported using CIFs to estimate the incidence of the outcome over time in the presence of competing risks. The second
review examined how authors interpreted the hazard ratios arising from a Fine-Gray subdistribution hazard model.11
We found that many authors had an incorrect or unclear interpretation of the estimated subdistribution hazard ratios. In
that review, we provided guidelines for interpreting the subdistribution hazard ratio resulting from a Fine-Gray compet-
ing risk regression model. The focus of the current review was on how authors in the biomedical literature incorporated
time-varying covariates in these models.
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In our current review, we found that 7% of studies that used the Fine-Gray subdistribution hazard model included
time-varying covariates in the model. In most instances, these were internal time-varying covariates. As noted above,
the inclusion of internal time-varying covariates can be problematic due to the unconventional definition of the risk set
that contains those who have experienced a competing event. In half of these studies, the competing event was either
all-cause mortality or cause-specific mortality. It is unclear how the time-varying covariates were defined following the
subject's death from a competing cause. Putting aside the concern about defining the time-varying covariate in subjects
who have experienced a competing event, as we have previously discussed, the inclusion of internal time-dependent
covariates implies that the resultantmodel is no longer amodel for the CIF. Thus, one cannotmake claims about the asso-
ciation of the covariate with increased risk of the event. Despite this limitation, half of the studies that included internal
time-varying covariates interpreted a time-varying covariate as having an effect on the risk of the occurrence of the event of
interest.
Statistical software packages differ in their ability to incorporate time-varying covariates in the Fine-Gray subdistri-
bution hazard regression model. The crr function in the cmprsk package for R permits the inclusion of continuous
time-varying covariates that are interactions of time-invariant covariates and known polynomial functions of time. Thus,
it does not permit the inclusion of binary or categorical time-varying covariates (these models can also be fit using func-
tions from the riskRegression package, which provide a formula interface similar to that in the survival package). In
contrast to this, both the stcrreg function in Stata and the PHREG procedure in SAS permit the inclusion of both con-
tinuous and categorical time-varying covariates. Regardless of the capabilities of a given statistical software package, one
must exercise extreme caution in the interpretation of the resultant model.
We summarize our recommendations as follows. First, external time-dependent covariates may be included in the
Fine-Gray subdistribution hazardmodel. However, analysts must interpret the resultantmodel carefully, as the estimated
regression coefficients no longer describe the association of the covariate with the CIF. Thus, the fitted model loses its
original attractive feature: the ability to directly estimate the association between covariates and the CIF. The interpreta-
tion of the covariate effects on the CIF requires careful consideration, similarly to the proportional hazards model with
external time-dependent covariates in the absence of competing risks. For a fixed realization of the external time-varying
covariate, the CIF may be calculated via either analytic or numerical integration, permitting a comparison of the risks for
subjects with different time-varying covariates. For the case of ordered covariates, there is a simple ordering of the CIFs
based on the sign of the regression coefficient in the proportional subdistribution hazard regression model.
Second, analysts should exercise extreme caution in including internal time-varying covariates in the Fine-Gray sub-
distribution hazard model. The nature of the subdistribution hazard risk set can make defining the covariates difficult
for subjects who have experienced a competing event. Furthermore, one can no longer make inferences (either directly
or via integration) about the effect of the covariate on the CIF. Finally, based on the findings of Poguntke et al, there is
the risk that the estimated subdistribution hazard ratio based on the assumed covariate definition may be misleading,
yielding unclear inferences. While we are reluctant to suggest that internal time-varying should never be included in a
Fine-Gray subdistribution hazard model, these arguments suggest that their inclusion should be rare and that analysts
should proceed with utmost caution.
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APPENDIX
Given the Cox proportional hazards model, we have that
𝜆(t|X) = 𝜆0(t)e𝛃X, integrating both sides yields
t
∫
0
𝜆(s|X)ds =
t
∫
0
𝜆0(s)e𝛃Xds,
t
∫
0
𝜆(s|X)ds = e𝛃X
t
∫
0
𝜆0(s)ds (𝛽X is constantso it canbetaken outside the integral sign)
Λ(t|X) = e𝛃XΛ0(t)
−log (S(t|X)) = e𝛃X (−log(S0(t)))
log (S(t|X)) = log(S0(t)e𝛃X
)
S(t|X) = S0(t)e𝛃X .
